Related Experiment Videos
Should diabetes be a contraindication for an intraocular lens?
Summary
Binkhorst 4-loop intraocular lenses allow good visualization of the fundus for diabetic retinopathy treatment. Argon laser photocoagulation is feasible, suggesting iris clip lenses are suitable for selected diabetic patients.
Area of Science:
- Ophthalmology
- Medical Devices
- Diabetic Retinopathy
Background:
- Intraocular lenses (IOLs) are commonly used in cataract surgery.
- Diabetic retinopathy is a leading cause of vision loss in diabetic patients.
- The impact of specific IOL designs on the management of diabetic retinopathy requires evaluation.
Purpose of the Study:
- To assess the feasibility of visualizing the fundus in patients with Binkhorst 4-loop intraocular lenses.
- To determine the efficacy of treating diabetic retinopathy in these patients.
- To evaluate the suitability of iris clip lenses for diabetic patients.
Main Methods:
- Study included 25 patients with Binkhorst 4-loop IOLs meeting pre-operative criteria.
- Fundus visualization assessed using direct ophthalmoscope and posterior pole contact lens.
- Fundus photography and fluorescein angiography performed with dilated pupils.
- Retinal photocoagulation with argon laser was administered as needed.
Main Results:
- Good fundus visualization was achieved in most patients with undilated pupils.
- Fundus documentation required pupil dilation.
- Argon laser photocoagulation was successfully performed through the IOLs in all treated patients.
- No contraindications were found for iris clip lenses in selected diabetic patients.
Conclusions:
- Binkhorst 4-loop IOLs facilitate adequate fundus visualization for diabetic retinopathy management.
- Iris clip lenses are a viable option for selected diabetic patients requiring intraocular lens implantation.
- Further research may explore long-term outcomes and specific patient selection criteria.